RYTM
Rhythm Pharmaceuticals Inc
90.80$
+1.3%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +17.6% | +620.0% | +0.0% | +0.0% | +54.9% | +98.2% | +88.7% | -17.3% | +67.8% | +44.4% | +5.1% | -11.1% | -14.4% | |
| – | – | -48.0% | +351.5% | +291.9% | +95.0% | +180.5% | +85.8% | +47.0% | +19.2% | -4.7% | +64.2% | +21.9% | +68.4% | |
| – | – | – | +2,507.6% | -31.5% | +244.8% | +57.2% | +85.8% | +45.0% | +19.4% | -1.0% | – | – | – | |
| – | +895.0% | -140.1% | – | -44.0% | -102.9% | – | +659.7% | -216.3% | – | -1,139.7% | – | +120.0% | -109.2% | |
| – | – | – | +0.0% | +6,117.6% | -87.4% | +442.9% | +368.8% | -93.7% | +2,439.3% | -21.2% | -98.9% | -100.0% | – | |
| – | -2.7% | -99.7% | +0.0% | +29,958.8% | +2,053.5% | -20.8% | -67.9% | – | -139.2% | – | -120.2% | +750.4% | +184.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | +35.5% | |
| – | – | – | +462.2% | +202.9% | +32.3% | -1.5% | -0.7% | -98.8% | +8,186.8% | -15.0% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -11.4% | -62.7% | +462.2% | -100.0% | – | -1.5% | -0.7% | -98.8% | +8,186.8% | +28.4% | -65.2% | +157.2% | +14.0% | |
| – | – | – | – | -181.6% | – | -44.1% | -17.6% | +202.3% | -208.1% | – | -198.8% | – | -219.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.